These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8768660)

  • 1. [The evolution of pharmaceutical services and drug consumption in Spain].
    del Río MC; Alvarez FJ
    Aten Primaria; 1996; 18(3):148-9. PubMed ID: 8768660
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug atlas corrects political reproaches: why drug expenditures of GKV are really increasing].
    Schmidt K
    MMW Fortschr Med; 2007 Mar; 149(9):50-1. PubMed ID: 17612254
    [No Abstract]   [Full Text] [Related]  

  • 3. [The need for joint evaluation of pharmaceutical expenditure and the health outcomes obtained].
    Soto Álvarez J
    Gac Sanit; 2011; 25(3):257. PubMed ID: 21459490
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceutical reform in South Korea and the lessons it provides.
    Kim HJ; Ruger JP
    Health Aff (Millwood); 2008; 27(4):w260-9. PubMed ID: 18508813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter from Bristol.
    Graham C; Rai D
    Natl Med J India; 2017; 30(6):356-357. PubMed ID: 30117454
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of medication use in Scotland.
    Covvey JR; McTaggart S; Bishop I
    Am J Health Syst Pharm; 2010 Aug; 67(16):1378-82. PubMed ID: 20689130
    [No Abstract]   [Full Text] [Related]  

  • 7. The drug budget silo mentality in Europe: an overview.
    Garrison L; Towse A
    Value Health; 2003; 6 Suppl 1():S1-9. PubMed ID: 12846921
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 9. By the Numbers. Prescription drugs and supplies.
    Mod Healthc; 2001 Dec; 31(52 Suppl):30. PubMed ID: 11808395
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistics and drug utilization: are prescribing rates really that high?
    Morgan S
    CMAJ; 2001 Nov; 165(11):1507-8. PubMed ID: 11762577
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
    Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
    Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A decalog for rationalizing health expenditure in Spain].
    Labay Matías M
    An Esp Pediatr; 1996 Jan; 44(1):79-80. PubMed ID: 8849071
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care spending slowing.
    Sibbald B
    CMAJ; 2001 Nov; 165(11):1524. PubMed ID: 11762583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities].
    Andreasen J
    Ugeskr Laeger; 2003 Jul; 165(29):2873-6. PubMed ID: 12908355
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare: where have we been? Where are we going?
    Deeble J
    Aust N Z J Public Health; 1999 Dec; 23(6):563-70. PubMed ID: 10641344
    [No Abstract]   [Full Text] [Related]  

  • 16. Balancing drug costs and prescribing needs.
    Contract Healthc; 1988 Jul; ():18-9. PubMed ID: 10290586
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 18. Health care in the Spanish social security system: public-private relationships.
    Kelley JB
    Int J Health Serv; 1984; 14(2):309-20. PubMed ID: 6735544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorting out contradictions within managed care.
    Navarro RP
    Med Interface; 1996 Sep; 9(9):85-6. PubMed ID: 10161524
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug trend slows in 2003, but higher utilization still driving costs.
    Capitation Rates Data; 2004 Jul; 9(7):78-82. PubMed ID: 15341340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.